5Hatorp V,Huang WC,Strange P.Pharmacokinetic profiles of repaglinide in elderly subjects with type 2 diabetes[].The Journal of Clinical Endocrinology.1999
6Vinambres C,Villanueva-penacarrillo ML,Malaisse WJ.Repaglinide preserves nutrient-stimulated biosynthetic activity in rat pancreatic islets[].Pharmacological Research.1996
7Marbury TC,Hatorp V,Damsbo P,et al.Repaglinide can be given in the flexible preprandial dosing regimen in patients with type 2 diabetes[].Diabetes.1998
8Goldberg RB,Brodows RG,Damsbo P.A randomized, placebocontrolled trial of repaglinide in the treatment of type 2 diabetes[].Diabetes.1998
9Berger S,Strange P.Repaglinide, a novel oral hypoglycemic agent in type 2 diabetes: A randomized, placebo-controlled, double-blind, fixed-dose study[].Diabetes.1998
10Fuhlendorff J,Rorsman P,Kofod H,et al.Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes[].Diabetes.1998
